Literature DB >> 1680551

Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma.

D Millikin1, E Meese, B Vogelstein, C Witkowski, J Trent.   

Abstract

Malignant melanoma has been documented to display recurring abnormalities of chromosome 6, particularly the long arm (6q). Restriction fragment length polymorphism analysis was used as a molecular genetic approach to examine loci on chromosome 6q for loss of constitutional heterozygosity (LOH). Five DNA markers that recognize restriction fragment length polymorphisms along 6q and one polymorphic DNA marker for 6p were used to screen 20 autologous pairs of tumor DNA and normal DNA to determine the tumor and constitutional genotypes of each patient. LOH on chromosome 6q was identified at 21 of 53 informative loci (40%). Five patients with more than one informative locus had allele losses consistent with the loss of the entire long arm (or of an entire copy) of chromosome 6, while four other patients demonstrated terminal deletions of 6q. The chromosomal region bearing the highest frequency of 6q allelic loss (60%) is defined by the marker loci c-MYB and ESR (6q22-23 and 6q24-27). In contrast to the frequency of 6q loss, LOH was observed at loci on four other chromosomes (1, 11, 16, 17) in only 5% of cases. These results have led us to conclude that the loss of sequences from the long arm of chromosome 6 is a nonrandom and possibly biologically relevant event in human malignant melanoma.

Entities:  

Mesh:

Year:  1991        PMID: 1680551

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

1.  Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization.

Authors:  E J Speel; J Richter; H Moch; C Egenter; P Saremaslani; K Rütimann; J Zhao; A Barghorn; J Roth; P U Heitz; P Komminoth
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.

Authors:  S F Huang; S Xiao; A A Renshaw; K R Loughlin; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  An accurate and powerful method for copy number variation detection.

Authors:  Feifei Xiao; Xizhi Luo; Ning Hao; Yue S Niu; Xiangjun Xiao; Guoshuai Cai; Christopher I Amos; Heping Zhang
Journal:  Bioinformatics       Date:  2019-09-01       Impact factor: 6.937

4.  Alterations in patient plasma microRNA expression profiles following resection of metastatic melanoma.

Authors:  Nicholas Latchana; Mallory J DiVincenzo; Kelly Regan; Zachary Abrams; Xiaoli Zhang; Naduparambil K Jacob; Alejandro A Gru; Paolo Fadda; Joseph Markowitz; J Harrison Howard; William E Carson
Journal:  J Surg Oncol       Date:  2018-08-21       Impact factor: 3.454

5.  Tumour-cell-endothelial interactions: free radicals are mediators of melanoma-induced endothelial cell damage.

Authors:  F A Offner; J Schiefer; H C Wirtz; I Bigalke; M Pavelka; G Hollweg; C Ensinger; B Klosterhalfen; C Mittermayer; C J Kirkpatrick
Journal:  Virchows Arch       Date:  1996-05       Impact factor: 4.064

Review 6.  Liquid Biopsies for Assessing Metastatic Melanoma Progression.

Authors:  Kelly Huynh; Dave S B Hoon
Journal:  Crit Rev Oncog       Date:  2016

7.  PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family.

Authors:  L D Attardi; E E Reczek; C Cosmas; E G Demicco; M E McCurrach; S W Lowe; T Jacks
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

8.  A major lung cancer susceptibility locus maps to chromosome 6q23-25.

Authors:  J E Bailey-Wilson; C I Amos; S M Pinney; G M Petersen; M de Andrade; J S Wiest; P Fain; A G Schwartz; M You; W Franklin; C Klein; A Gazdar; H Rothschild; D Mandal; T Coons; J Slusser; J Lee; C Gaba; E Kupert; A Perez; X Zhou; D Zeng; Q Liu; Q Zhang; D Seminara; J Minna; M W Anderson
Journal:  Am J Hum Genet       Date:  2004-07-21       Impact factor: 11.025

9.  Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells.

Authors:  S L Church; J W Grant; L A Ridnour; L W Oberley; P E Swanson; P S Meltzer; J M Trent
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  Down-regulation of a novel actin-binding molecule, skeletrophin, in malignant melanoma.

Authors:  Tamotsu Takeuchi; Henry H Q Heng; Christine J Ye; Sheng-Ben Liang; Jun Iwata; Hiroshi Sonobe; Yuji Ohtsuki
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.